MedPath

Surgical Eradication of Deep Infiltrating Endometriosis of the Vagina

Not Applicable
Completed
Conditions
Endometriosis
Interventions
Procedure: Removal of vaginal endometriotic nodule
Procedure: longitudinal suture
Procedure: transverse suture
Registration Number
NCT03744143
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Brief Summary

Multicentric retrospective study about the comparison of two different techniques of vaginal breach suturing after eradication surgery for deep infiltrating endometriosis and the surgical approaches (laparoscopic or vaginal) in terms of surgical, clinical and functional outcomes.

Detailed Description

Treatment of vaginal endometriosis can be successfully performed by vaginal or laparoscopic approach.

The results of the surgical treatment confirm its validity with regard to the reduction of dyspareunia in the short to medium term but show less efficacy in the long follow-up. The long-term impact of surgery on sexual function may be influenced by multiple factors, such as recurrence of symptomatic or anatomical disease, preservation of autonomic nerve fibers responsible for the arousal and genital sensitivity and residual vaginal length. These factors are potentially dependent on the surgical approach performed to treat vaginal endometriosis.

Particular importance as a surgical step assumes the closing phase of the vaginal defect that can be performed through a transverse or longitudinal suture. The longitudinal suture could guarantee, theoretically, a greater residual vaginal length and a better sexual function in the postoperative period than the vaginal closure by transversal suture, as demonstrated in previous studies about the suture techniques of vaginal cuff after hysterectomy.

Up to date, there are no studies comparing surgical, clinical and functional outcomes of the vaginal suture neither the two surgical approaches (laparoscopic or vaginal) for vaginal endometriosis eradication.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
84
Inclusion Criteria
  • Clinical diagnosis of vaginal endometriosis
  • Women undergoing surgical removal with complete endometriotic lesions involving the vagina
  • Informed consent for the processing of personal data for scientific purposes
Exclusion Criteria
  • History of previous or ongoing neoplastic pathology
  • Patients committed to hysterectomy
  • Previous vaginal surgery
  • Not complete eradicating surgery
  • Vaginism-vulvodynia
  • Psychiatric disorders
  • Genital prolapse
  • Surgical menopause or spontaneous or pharmacological menopause

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group A (vaginal technique)Removal of vaginal endometriotic nodulePatients undergoing surgical removal of vaginal endometriotic nodule through vaginal technique
Group B (laparoscopic technique)longitudinal suturePatients undergoing surgical removal of vaginal endometriotic nodule through laparoscopic technique. Closure of the vagina with a transverse suture or a longitudinal suture.
Group B (laparoscopic technique)Removal of vaginal endometriotic nodulePatients undergoing surgical removal of vaginal endometriotic nodule through laparoscopic technique. Closure of the vagina with a transverse suture or a longitudinal suture.
Group B (laparoscopic technique)transverse suturePatients undergoing surgical removal of vaginal endometriotic nodule through laparoscopic technique. Closure of the vagina with a transverse suture or a longitudinal suture.
Primary Outcome Measures
NameTimeMethod
Operative timeIntraoperative

To compare the surgical techniques of vaginal endometriotic nodule removal considering the operative time

Secondary Outcome Measures
NameTimeMethod
Complication rateup to 30 days after surgery; from date of surgery until the date of first documented complication, assessed up to 30 days

Comparison of laparoscopic and vaginal approach concerning complication rate in patients affected by vaginal endometriosis, using Clavien-Dindo Classification.

Evaluation of dyspareunia recurrence rateUp to 6 months after surgery

Reappearance of dyspareunia in patients underwent different surgical techniques, assessed using a visual analog score, equal to or greater than 5

Evaluation of disease recurrence rateUp to 6 months after surgery; from date of surgery until the date of first clinical or trans-vaginal/abdominal ultrasound documented recurrence, assessed up to 6 months

Reappearance of vaginal nodule / rectum-vaginal septum in patients underwent different surgical techniques

Trial Locations

Locations (2)

Policlinico Universitario Agostino Gemelli

🇮🇹

Roma, Italy

Gynecology and Physiopathology of Human Reproductive Unit, University of Bologna, S. Orsola-Malpighi Hospital

🇮🇹

Bologna, BO, Italy

© Copyright 2025. All Rights Reserved by MedPath